Fwd: HIV Research Fellowship and Merck Innovation Program in Germany

3 views
Skip to first unread message

Okechukwu Ogah

unread,
Jan 27, 2025, 12:05:17 AMJan 27
to nigerian-car...@googlegroups.com

Dr O.S Ogah. MBBS, MSc, PhD, MD, FWACP, FACP, FESC, FNCS

A. Senior Lecturer
Cardiology Unit, Department of Medicine,
Faculty of Clinical Sciences
College of Medicine,
University of Ibadan, NIGERIA

B. Honorary Consultant Physician/Cardiologist,
Cardiology Unit,
Department of Medicine
University College Hospital Ibadan, NIGERIA

PERSONAL POSTAL ADDRESS
P.O BOX 14343, UNIVERSITY OF IBADAN  POST OFFICE
IBADAN, NIGERIA

Tel. +234 806 77 47 121
Fax. +1215-975-6817 (Electronic)
Emails: 

C. Bernard Lown Visiting Scholar in Cardiovascular Health
Department of Global Health and Population
Harvard T.H. Chan School of Public Health

D. Adjunct Researcher,
Institute of Advanced Medical Research and Training (IAMRAT)
College of Medicine, University of Ibadan, NIGERIA

E. Affiliate Member,
The Hatter Institute for Cardiovascular Research in Africa (HICRA)
4th Floor Chris Barnard Building
Faculty of Health Sciences
University of Cape Town
Private Bag X3 7935
Observatory, SOUTH AFRICA


F. Past President,
Nigerian Cardiac Society

--------------------------------------------------------------------------------------------------------------------------------------------------

"For with thee is the fountain of life: in thy light shall we see light." Psalm 36:9

-------------------------------------------------------------------------------------------------



---------- Forwarded message ---------
From: Susan Snyder <sup...@trialect.com>
Date: Mon, Jan 27, 2025 at 5:30 AM
Subject: HIV Research Fellowship and Merck Innovation Program in Germany
To: <osoga...@gmail.com>


HIV Research Fellowship and Merck Innovation Program in Germany ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ 

Dear Dr. Okechukwu

­

HIV Research Fellowship


Prof. Carsten Muenk at the University Hospital Düsseldorf, Germany, invites interested faculty and fellows for a short-term research fellowship/colleagueship in HIV Molecular Research on Trialect's SeizFire Platform.  Please refer your students or colleagues to explore and apply at  HIV Research.

 

Merck KGaA Innovation Program for Young Scientists

 

We have a posting on Trialect soliciting applications for the Merck KGaA Innovation Program. This program invites applications from young biomedical scientists worldwide. Approximately 42 international students will be selected to participate in the Innovation Camp, scheduled to take place from July 19–25, 2025, near Frankfurt, Germany. Merck will cover travel, accommodation, and food expenses fully. As the deadline is approaching, please refer your students to Explore Here

­

Please feel free to share with your colleagues or students 

Regards,


Susan Snyder

Support Specialist

The SeizFIRE Platform

Trialect Inc, Thousand Oaks, CA, USA

sup...@trialect.com

+1.805.852.1402
Note: This is a trialect partnered program. All applications only have to go through the Trialect SeizFire Platform.  

­
­
­
­
­
­

Disclaimer: 
You are receiving this email based on your expertise and past work as determined by the sponsors or by our scientific affairs. Trialect Inc is a United States Incorporation that posts grants, fellowships, courses, and industry-academia partnerships to professionals in the healthcare industry. We are in no way affiliated with, endorsed, or supported by the sponsors.

This email was sent to osoga...@gmail.com

You've received it because you've subscribed to our newsletter.

Reply all
Reply to author
Forward
0 new messages